Reducing Activities: company scaling back some business operations while continuing others
Wait Scaling Back
Astellas Pharma
Astellas Pharma
Reducing Activities: company scaling back some business operations while continuing others
Wait Scaling BackRevenue(RF), mln.USD
273
Staff
22
Capital, mln.USD
162
Glob.Revenue, mln.USD
9600
The Company Statement
Suspended new clinical trials in Russia
All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.